Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution

被引:12
作者
Wu, Yibo [1 ,2 ,3 ,4 ]
Lai, Xiaoyu [1 ,2 ,3 ,4 ]
Shi, Jimin [1 ,2 ,3 ,4 ]
Tan, Yamin [5 ]
Zhao, Yanmin [1 ,2 ,3 ,4 ]
Yu, Jian [1 ,2 ,3 ,4 ]
Liu, Lizhen [1 ,2 ,3 ,4 ]
Zhang, Wei [6 ]
Huang, He [1 ,2 ,3 ,4 ]
Luo, Yi [1 ,2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China
[2] Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China
[3] Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Peoples R China
[4] Zhejiang Univ, Med Ctr, Liangzhu Lab, Hangzhou, Peoples R China
[5] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Beijing, Peoples R China
[6] Blood Ctr Zhejiang Prov, HLA Typing Lab, Hangzhou, Peoples R China
关键词
haploidentical; haematopoietic stem cell transplantation; donor selection; donor characteristics; donor age; female to male; BONE-MARROW-TRANSPLANTATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; HEMATOLOGIC MALIGNANCIES; ABO INCOMPATIBILITY; PEDIATRIC-PATIENTS; HLA DISPARITY; OUTCOMES; DISEASE;
D O I
10.1111/bjh.17978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the most complex issues with haploidentical stem cell transplantation (haplo-SCT) is donor selection, given that multiple haploidentical donors are often available for a given recipient. To develop evidence-based guidance for donor selection in the setting of anti-thymocyte globulin-based haplo-SCT, we performed a prospective cohort study of 512 patients with haematological malignancies who had haplo-SCT to determine which donor variables were most important in favouring transplant outcomes. Increasing donor age was associated with poorer overall survival (OS) [hazard ratio (HR) 1 center dot 08, P = 0 center dot 044]. Female donors to male recipients was significantly associated with higher non-relapse mortality (NRM; HR 2 center dot 05, P = 0 center dot 006). Furthermore, increasing donor age had a higher risk of Grades 3-4 acute graft-versus-host disease (aGVHD; HR 1 center dot 17, P = 0 center dot 005), female donors to male recipients was associated with a higher risk of Grades 2-4 aGVHD (HR 1 center dot 50, P = 0 center dot 022). Sibling donors had superior OS, disease-free survival, and NRM than parental donors in patients aged <35 years. However, sibling donors had higher NRM than offspring donors in patients aged >= 35 years. A younger donor, usually a young sibling in younger recipients (aged <35 years) or a young offspring in older patients (aged >= 35 years) and avoiding female donors to male recipients should be preferred when multiple haploidentical donors are available.
引用
收藏
页码:1225 / 1238
页数:14
相关论文
共 53 条
[1]   Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation [J].
Al Malki, Monzr M. ;
Yang, Dongyun ;
Labopin, Myriam ;
Afanasyev, Boris ;
Angelucci, Emanuele ;
Bashey, Asad ;
Socie, Gerard ;
Karduss-Urueta, Amado ;
Helbig, Grzegorz ;
Bornhauser, Martin ;
Niittyvuopio, Riitta ;
Ganser, Arnold ;
Ciceri, Fabio ;
Brecht, Arne ;
Koc, Yener ;
Bejanyan, Nelli ;
Ferraro, Francesca ;
Kebriaei, Partow ;
Mokhtari, Sally ;
Ghobadi, Armin ;
Nakamura, Ryotaro ;
Forman, Stephen J. ;
Champlin, Richard ;
Mohty, Mohamad ;
Ciurea, Stefan O. ;
Nagler, Arnon .
BLOOD ADVANCES, 2020, 4 (09) :2073-2083
[2]   Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation [J].
Armand, Philippe ;
Kim, Haesook T. ;
Logan, Brent R. ;
Wang, Zhiwei ;
Alyea, Edwin P. ;
Kalaycio, Matt E. ;
Maziarz, Richard T. ;
Antin, Joseph H. ;
Soiffer, Robert J. ;
Weisdorf, Daniel J. ;
Rizzo, J. Douglas ;
Horowitz, Mary M. ;
Saber, Wael .
BLOOD, 2014, 123 (23) :3664-3671
[3]   T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation [J].
Bashey, Asad ;
Zhang, Xu ;
Sizemore, Connie A. ;
Manion, Karen ;
Brown, Stacey ;
Holland, H. Kent ;
Morris, Lawrence E. ;
Solomon, Scott R. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) :1310-1316
[4]   Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study [J].
Bazarbachi, Ali ;
Boumendil, Ariane ;
Finel, Herve ;
Castagna, Luca ;
Dominietto, Alida ;
Blaise, Didier ;
Diez-Martin, Jose L. ;
Tischer, Johanna ;
Gulbas, Zafer ;
Wallet, Helene L. ;
Corral, Lucia L. ;
Mohty, Mohamad ;
Koc, Yener ;
Yakoub-Agha, Ibrahim ;
Schmid, Christoph ;
El Cheikh, Jean ;
Arat, Mutlu ;
Forcade, Edouard ;
Dreger, Peter ;
Rocha, Vanderson ;
Garcia, Gonzalo G. ;
Chalandon, Yves ;
Ferra, Christelle ;
Orvain, Corentin ;
Robinson, Stephen ;
Montoto, Silvia ;
Sureda, Anna .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (05) :745-756
[5]   Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study [J].
Berger, Massimo ;
Lanino, Edoardo ;
Cesaro, Simone ;
Zecca, Marco ;
Vassallo, Elena ;
Faraci, Maura ;
De Bortoli, Massimiliano ;
Barat, Veronica ;
Prete, Arcangelo ;
Fagioli, Franca .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) :902-909
[6]   Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation [J].
Canaani, Jonathan ;
Savani, Bipin N. ;
Labopin, Myriam ;
Huang, Xiao-Jun ;
Ciceri, Fabio ;
Arcese, William ;
Koc, Yener ;
Tischer, Johanna ;
Blaise, Didier ;
Gulbas, Zafer ;
Van Lint, Maria Teresa ;
Bruno, Benedetto ;
Mohty, Mohamad ;
Nagler, Arnon .
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (02) :246-253
[7]   Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT [J].
Canaani, Jonathan ;
Savani, Bipin N. ;
Labopin, Myriam ;
Huang, Xiao-jun ;
Ciceri, Fabio ;
Arcese, William ;
Tischer, Johanna ;
Koc, Yener ;
Bruno, Benedetto ;
Gulbas, Zafer ;
Blaise, Didier ;
Maertens, Johan ;
Ehninger, Gerhard ;
Mohty, Mohamad ;
Nagler, Arnon .
HAEMATOLOGICA, 2017, 102 (06) :1066-1074
[8]   Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients [J].
Castagna, Luca ;
Busca, Alessandro ;
Bramanti, Stefania ;
Anna, Maria Raiola ;
Malagola, Michele ;
Ciceri, Fabio ;
Arcese, William ;
Vallisa, Daniele ;
Patriarca, Francesca ;
Specchia, Giorgina ;
Raimondi, Roberto ;
Devillier, Raynier ;
Furst, Sabine ;
Giordano, Laura ;
Sarina, Barbara ;
Mariotti, Jacopo ;
Olivieri, Attilio ;
Bouabdallah, Reda ;
Carlo-Stella, Carmelo ;
Rambaldi, Alessandro ;
Santoro, Armando ;
Corradini, Paolo ;
Bacigalupo, Andrea ;
Bonifazi, Francesca ;
Blaise, Didier .
BMC CANCER, 2020, 20 (01)
[9]   Effects of pre- and post-transplantation minimal residual disease on outcomes in pediatric patients with acute myeloid leukemia receiving human leukocyte antigen-matched or mismatched related donor allografts [J].
Chang, Ying-Jun ;
Zhao, Xiao-Su ;
Wang, Yu ;
Liu, Yan-Rong ;
Xu, Lan-Ping ;
Zhang, Xiao-Hui ;
Chen, Huan ;
Chen, Yu-Hong ;
Han, Wei ;
Sun, Yu-Qian ;
Yan, Chen-Hua ;
Mo, Xiao-Dong ;
Liu, Kai-Yan ;
Huang, Xiao-Jun .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) :E659-E661
[10]   Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis [J].
Chang, Ying-Jun ;
Wang, Yu ;
Liu, Yan-Rong ;
Xu, Lan-Ping ;
Zhang, Xiao-Hui ;
Chen, Huan ;
Chen, Yu-Hong ;
Wang, Feng-Rong ;
Han, Wei ;
Sun, Yu-Qian ;
Yan, Chen-Hua ;
Tang, Fei-Fei ;
Mo, Xiao-Dong ;
Liu, Kai-Yan ;
Huang, Xiao-Jun .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10